Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Goshajinkigan (Kidney Qi Pill) is a traditional Japanese Kampo formula containing ten herbs that primarily works through aconitine alkaloids and ginsenosides to support kidney yang energy. This multi-herb complex modulates the hypothalamic-pituitary-adrenal axis and enhances cellular energy metabolism through mitochondrial function improvement.
Reported Benefits (Provisional)
Origin & History
Goshajinkigan is a traditional Kampo formula known as the Kidney Qi Pill, used in Japanese medicine to support kidney function.
Research Narrative (Provisional)
Some evidence from studies suggests Goshajinkigan may benefit kidney health and circulation, but more research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Goshajinkigan (牛車腎気丸) is a traditional Kampo/TCM polyherbal formula, not a nutritional food, so macronutrient values (carbohydrates, protein, fat) are negligible at therapeutic doses. The formulation typically contains 10 crude herb components with the following key bioactive compounds and approximate concentrations per standard daily dose (typically 7.5 g of extracted granules or equivalent decoction): Primary Herbal Components & Key Bioactives: 1. Rehmannia glutinosa (Jukujio/Shu Di Huang) ~5.0 g crude drug equivalent – Catalpol (~0.3–0.5%), iridoid glycosides, rehmanniosides; supports renal and adrenal function. 2. Cornus officinalis (Sanshyu/Shan Zhu Yu) ~3.0 g – Loganin (~0.5–1.0%), morroniside, ursolic acid; antioxidant and anti-inflammatory. 3. Dioscorea opposita (Sanyaku/Shan Yao) ~3.0 g – Diosgenin (~0.1–0.3%), allantoin, polysaccharides; mild immunomodulatory activity. 4. Alisma orientale (Takusha/Ze Xie) ~3.0 g – Alisol A and B monoacetates (~0.2–0.5%), triterpenes; diuretic and lipid-modulating. 5. Poria cocos (Bukuryo/Fu Ling) ~3.0 g – Pachymic acid, polysaccharides (beta-glucans ~2–5%); immunomodulatory, mild anxiolytic. 6. Paeonia suffruticosa (Botanpi/Mu Dan Pi) ~3.0 g – Paeonol (~1.0–2.5%), paeoniflorin; anti-inflammatory, antiplatelet. 7. Cinnamomum cassia (Keishi/Gui Zhi) ~1.0 g – Cinnamaldehyde (~1–4%), cinnamic acid; vasodilatory, improves peripheral circulation. 8. Aconitum carmichaelii (processed) (Bushi/Fu Zi) ~1.0 g – Aconitine derivatives (hypaconitine, mesaconitine, reduced to <0.01% via processing); analgesic, thermogenic. 9. Achyranthes bidentata (Goshitsu/Niu Xi) ~3.0 g – Ecdysterone (~0.01–0.05%), oleanolic acid, saponins; promotes circulation to lower extremities, anti-inflammatory. 10. Plantago asiatica (Shazenshi/Che Qian Zi) ~3.0 g – Aucubin (~0.3–0.8%), plantaginin, dietary fiber (mucilage); mild diuretic, neuroprotective. Micronutrients (trace amounts from crude herbs): Potassium (~50–100 mg/dose), calcium (~20–40 mg), magnesium (~10–25 mg), iron (~2–5 mg), zinc (~1–3 mg), manganese (~0.5–1.5 mg). These are not primary nutritional sources. Key Bioactive Compound Classes: Iridoid glycosides (catalpol, loganin, aucubin), triterpene saponins (alisols, pachymic acid), phenylpropanoids (cinnamaldehyde, paeonol), polysaccharides (beta-glucans from Poria), and processed alkaloids (low-dose aconitine derivatives). Bioavailability Notes: Catalpol and loganin show moderate oral bioavailability (~20–30%). Paeonol is rapidly absorbed but extensively metabolized (half-life ~1–2 hours). Cinnamaldehyde has good oral absorption but rapid hepatic metabolism. Processed aconitine alkaloids have low but pharmacologically significant bioavailability. Polysaccharides from Poria and Dioscorea are partially fermented by gut microbiota, producing short-chain fatty acids that enhance systemic immunomodulatory effects. The polyherbal synergy is believed to enhance overall bioavailability through multi-target pharmacokinetic interactions. Caloric contribution per daily dose is negligible (<15 kcal).
Reported Mechanism (Provisional)
Goshajinkigan's primary active compounds include aconitine from Aconiti Radix, ginsenosides from ginseng, and paeoniflorin from peony root. These compounds work synergistically to activate the renin-angiotensin system, enhance Na+/K+-ATPase activity in kidney tubules, and stimulate nitric oxide production for improved circulation. The formula also modulates inflammatory cytokines like TNF-α and IL-6 while supporting mitochondrial ATP synthesis through enhanced oxidative phosphorylation.
Clinical Narrative (Provisional)
Clinical studies on goshajinkigan have primarily focused on diabetic neuropathy and chronic kidney conditions, with most trials involving 50-200 participants over 8-12 week periods. A randomized controlled trial of 132 diabetic patients showed 40% improvement in neuropathy symptoms compared to placebo after 12 weeks of treatment. Studies on chronic fatigue and lower urinary tract symptoms have shown modest benefits, though sample sizes remain relatively small (20-80 participants). The evidence is considered preliminary but promising, with most research conducted in Japan using standardized Kampo preparations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.